UK - Accenture - Company Profile

Pierre Audoin Consultants (PAC)
February 27, 2012
SKU: PAC3873411
Anadarko Petroleum Corporation (APC: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/8/2014 | published by: Plunkett Research, Ltd.
Anadarko Petroleum Corporation (APC: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Anadarko Petroleum Corporation, APC: NYS) compared to  |  read more...
USD 1,795
AngioChem Inc. - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
AngioChem Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘AngioChem Inc. - Product Pipeline Review - 2014’, provides an overview of the AngioChem Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
AmVac AG - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
AmVac AG - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘AmVac AG - Product Pipeline Review - 2014’, provides an overview of the AmVac AG’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Alkermes Plc - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Alkermes Plc - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Alkermes Plc - Product Pipeline Review - 2014’, provides an overview of the Alkermes Plc’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Advicenne Pharma - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Advicenne Pharma - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Advicenne Pharma - Product Pipeline Review - 2014’, provides an overview of the Advicenne Pharma’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
ArmaGen Technologies, Inc. - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
ArmaGen Technologies, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘ArmaGen Technologies, Inc. - Product Pipeline Review - 2014’, provides an overview of the ArmaGen Technologies, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
arGEN-X BV - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
arGEN-X BV - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘arGEN-X BV - Product Pipeline Review - 2014’, provides an overview of the arGEN-X BV’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Apache Corp (APA: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/8/2014 | published by: Plunkett Research, Ltd.
Apache Corp (APA: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Apache Corp, APA: NYS) compared to its top  |  read more...
USD 1,795
AGY Therapeutics, Inc. - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
AGY Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘AGY Therapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the AGY Therapeutics, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Arisaph Pharmaceuticals, Inc. - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Arisaph Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Arisaph Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Arisaph Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
 

SELECT A LICENSE

    Online Download  USD 996  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!